(Q37098874)

English

Effective treatment of established human breast tumor xenografts in immunodeficient mice with a single dose of the alpha-emitting radioisotope astatine-211 conjugated to anti-HER2/neu diabodies

scientific article published on February 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Effective treatment of established human breast tumor xenografts in immunodeficient mice with a single dose of the alpha-emitting radioisotope astatine-211 conjugated to anti-HER2/neu diabodies (English)

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

breast neoplasm

1 reference

based on heuristic

inferred from title

tumour xenograft

1 reference

based on heuristic

inferred from title

Thomas Waldmann

8

object named as

Thomas A Waldmann

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

author name string

Matthew K Robinson

1

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Calvin Shaller

2

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Kayhan Garmestani

3

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Paul S Plascjak

4

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Kathryn M Hodge

5

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Qing-An Yuan

6

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

James D Marks

7

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Martin W Brechbiel

9

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Gregory P Adams

10

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

language of work or name

0 references

publication date

1 February 2008

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Clinical Cancer Research

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

14

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

875-882

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Arming antibodies: prospects and challenges for immunoconjugates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643368

14 September 2017

The promise of targeted {alpha}-particle therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643368

14 September 2017

Radioimmunotherapy with alpha-particle emitting radionuclides.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643368

14 September 2017

A single treatment of yttrium-90-labeled CHX-A"-C6.5 diabody inhibits the growth of established human tumor xenografts in immunodeficient mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643368

14 September 2017

Radioimmunotherapy with engineered antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643368

14 September 2017

Targeted actinium-225 in vivo generators for therapy of ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643368

14 September 2017

Tumor therapy with targeted atomic nanogenerators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643368

14 September 2017

Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2/neu

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643368

14 September 2017

In vitro and in vivo characterization of a human anti-c-erbB-2 single-chain Fv isolated from a filamentous phage antibody library

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643368

14 September 2017

"Diabodies": small bivalent and bispecific antibody fragments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643368

14 September 2017

Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643368

14 September 2017

Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643368

29 September 2017

Alpha-particle radioimmunotherapy of disseminated peritoneal disease using a (212)Pb-labeled radioimmunoconjugate targeting HER2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643368

29 September 2017

Preparation and in vivo evaluation of novel linkers for 211At labeling of proteins.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643368

29 September 2017

Antitumor effect of deferoxamine on human hepatocellular carcinoma growing in athymic nude mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643368

29 September 2017

Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643368

27 June 2018

Renal tubulointerstitial changes after internal irradiation with alpha-particle-emitting actinium daughters

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643368

3 September 2018

Efforts to control the errant products of a targeted in vivo generator

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643368

3 September 2018

Vascular-targeted radioimmunotherapy with the alpha-particle emitter 211At

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643368

3 September 2018

Preparation and in vivo evaluation of linkers for 211At labeling of humanized anti-Tac

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643368

3 September 2018

Construction, expression and characterisation of a single-chain diabody derived from a humanised anti-Lewis Y cancer targeting antibody using a heat-inducible bacterial secretion vector

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643368

3 September 2018

Mammalian expression and hollow fiber bioreactor production of recombinant anti-CEA diabody and minibody for clinical applications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2643368

3 September 2018

Radioimmunotherapy of neoplastic meningitis in rats using an alpha-particle-emitting immunoconjugate

1 reference

https://pubmed.ncbi.nlm.nih.gov/18245551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single-chain Fv

1 reference

https://pubmed.ncbi.nlm.nih.gov/18245551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preparation of 211At-labeled humanized anti-Tac using 211At produced in disposable internal and external bismuth targets

1 reference

https://pubmed.ncbi.nlm.nih.gov/18245551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibody therapy of cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18245551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Delivery of the alpha-emitting radioisotope bismuth-213 to solid tumors via single-chain Fv and diabody molecules

1 reference

https://pubmed.ncbi.nlm.nih.gov/18245551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A microdosimetric model of astatine-211 labeled antibodies for radioimmunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18245551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1158/1078-0432.CCR-07-1250

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37098874&oldid=1984682223"